PH Insights
Our take on topics and trends in health innovation
Navigating US healthcare reimbursement: taking digital health solutions to market
US healthcare reimbursement is complex. Understanding the ecosystem is critical to navigate routes to market for digital health solutions.
Generating evidence for AI solutions: understanding ‘model evidence’ and ‘solution evidence’
Trust is a core factor influencing the adoption of AI in healthcare. Vital to fostering this trust is robust evidence.
Generating evidence for AI in healthcare
A new white paper in development by Prova Health aims to clarify the evidence required for AI solutions in healthcare.
Improving the adoption of AI: clinician perspectives
Clinicians expect sufficient regulation and robust validation of AI-based medical devices. There remains a need for clear, AI-specific...
From data to insights: evidence for remote monitoring and wearables
Remote monitoring and wearables are promising solutions, which need evidence showing value for patients, clinicians and healthcare systems.
Evidence, reimbursement and routes to market in digital health
Optimising reimbursement models for digital health solutions is critical for improving the quality of solutions on the market, and boosting
Unlocking the potential of digital health: innovative approaches to evidence generation
Generating evidence for digital health solutions is a challenge. Novel approaches such as simulation, RWE and platform trials can help.
Demonstrating the value of digital health solutions with real-world evidence
Prova Health conducted an evaluation of Accurx's Self-Book product. This article shares some of the lessons we learned in the process.
Reaching a global consensus on evidence for digital health
A new white paper by Roche Information Solutions and Prova Health offers solutions on how to improve evidence standards and reimbursement...
The rising demand for evidence in digital health
Most digital solutions lack evidence, but more than ever innovators must show value to patients, clinicians, health systems and investors.